awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38552109-59B07C67-9D2D-47D3-8FCB-76F31645FD9F
Q38552109-59B07C67-9D2D-47D3-8FCB-76F31645FD9F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38552109-59B07C67-9D2D-47D3-8FCB-76F31645FD9F
Pharmacokinetic Aspects of Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitors.
P2860
Q38552109-59B07C67-9D2D-47D3-8FCB-76F31645FD9F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38552109-59B07C67-9D2D-47D3-8FCB-76F31645FD9F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c7aa0600626a7bf2b6c000784fbfe04e7f98d097
P2860
Phase I and pharmacokinetic study of daily oral AZD2171, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer: the National Cancer In